Acetylcholinesterase inhibitors attenuate atherogenesis in apolipoprotein E-knockout mice

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 52-58

  Inanaga, Keita ^a   Ichiki, Toshihiro ^a   Miyazaki, Ryohei ^a   Takeda, Kotaro ^a   Hashimoto, Toru ^a   Matsuura, Hirohide ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E knockout mice; Cholinesterase inhibitor; Cytokine; Donepezil; Oxidative stress

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; CYTOKINE; DONEPEZIL; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYSOSTIGMINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLINESTERASE INHIBITORS; CYTOKINES; INDANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PIPERIDINES; SEPSIS;

EID: 77958461188     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.027     Document Type: Article

References (30)

1. Schwartz P.J., La Rovere M.T. ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Autonomic Tone and Reflexes After Myocardial Infarction. Eur Heart J 1998, 19:1593-1595.
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9-13.
3. Li M., Zheng C., Sato T., et al. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004, 109:120-124.
4. Tsutsumi T., Ide T., Yamato M., et al. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc Res 2008, 77:713-721.
5. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
6. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
7. Wang H., Liao H., Ochani M., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004, 10:1216-1221.
8. de Jonge W.J., van der Zanden E.P., The F.O., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005, 6:844-851.
9. Heeschen C., Jang J.J., Weis M., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001, 7:833-839.
10. Hansen R.A., Gartlehner G., Webb A.P., et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin Interv Aging 2008, 3:211-225.
11. Reale M., Iarlori C., Gambi F., et al. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients. Exp Gerontol 2005, 40:165-171.
12. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens Suppl 2005, 23:S9-S17.
13. Ni W., Kitamoto S., Ishibashi M., et al. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004, 24:534-539.
14. Garrido A.M., Griendling K.K. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009, 302:148-158.
15. Handa T., Katare R.G., Kakinuma Y., et al. Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice. J Card Fail 2009, 15:805-811.
16. Bhat R.V., Turner S.L., Marks M.J., Collins A.C. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. J Pharmacol Exp Ther 1990, 255:187-196.
17. Miller F.J., Griendling K.K. Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol 2002, 353:220-233.
18. Chun H.J., Ali Z.A., Kojima Y., et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008, 18:3343-3354.
19. Brandes R.P., Schroder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med 2008, 18:15-19.
20. Custodis F., Baumhakel M., Schlimmer N., et al. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008, 117:2377-2387.
21. Singh S., Loke Y.K., Furberg C.D. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008, 300:1439-1450.
22. Tashkin D.P., Celli B., Senn S., et al. 4-Year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
23. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844.
24. Rull A., Beltrán-Debón R., Aragonès G., et al. Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet. Cytokine 2010, 50:121-128.
25. Rull A., Rodríguez F., Aragonès G., et al. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine 2009, 48:273-279.
26. Pepine C.J. The impact of nitric oxide in cardiovascular medicine: untapped potential utility. Am J Med 2009, 122:S10-S15.
27. Amenta F., Cavallotti C., Ferrante F., Zomparelli M. The cholinergic innervation of the aorta. Acta Histochem 1980, 66:197-203.
28. Wessler I., Kirkpatrick C.J., Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999, 26:198-205.
29. Saxena G., Singh S.P., Agrawal R., Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol 2008, 581:283-289.
30. Joven J., Rull A., Ferré N., et al. The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 2007, 195(2):e85-e92.